Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565.
Kelun-Biotech (Sichuan Kelun-Biotech Biopharmaceutical)
HKEX: 06990 ~$3B MCAP
Kelun-Biotech (Sichuan Kelun-Biotech Biopharmaceutical) is a biologics / adc company. See today's news for the latest developments.
Company Info
Sector:Biologics / ADC
Headquarters:Chengdu, Sichuan, China
Founded:1996
Website:www.kelun-biotech.com/
Upcoming Milestones & Key Dates
2026-07-28
Milestone
Initial profile created
Clinical Development Pipeline
See pipeline
Target: See pipelineRecent News
Leadership Team
See company website
Leadership team